tiprankstipranks
Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA

Medicenna Therapeutics Corp (MDNA) Stock News & Sentiment

140 Followers
Medicenna Gains CA$20M Boost for Cancer Immunotherapy
PremiumCompany Announcements
Medicenna Gains CA$20M Boost for Cancer Immunotherapy
3d ago
Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management
PremiumPress Releases
Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management
4d ago
Medicenna Unveils Key Immunotherapy Data at ASCO
PremiumCompany Announcements
Medicenna Unveils Key Immunotherapy Data at ASCO
5d ago
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
PremiumPress Releases
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
5d ago
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
PremiumPress Releases
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
20d ago
Medicenna’s MDNA11 Shows Promising Trial Results
PremiumCompany Announcements
Medicenna’s MDNA11 Shows Promising Trial Results
20d ago
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
PremiumPress Releases
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
20d ago
More TSE:MDNA News >

News Score - Last 7 Days

Neutral
TSE:MDNA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MDNA’s Media Buzz Sentiment?
1 articles about TSE:MDNA were published this week. In an average week, 1.5 articles are published.
    What is TSE:MDNA’s weekly average amount of articles?
    In an average week, 1.5 articles about TSE:MDNA are published.
      What is TSE:MDNA’s News Sentiment?
      50% of articles about TSE:MDNA were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        0HNZFagron SA
        ALPNAlpine Immune Sciences
        JANXJanux Therapeutics Inc
        SIGASIGA Technologies
        INNMFAmplia Therapeutics Ltd.
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis